Management of Low-Risk Papillary Thyroid Cancer.
10.3803/EnM.2018.33.2.185
- Author:
Nicole M IÑIGUEZ-ARIZA
1
;
Juan P BRITO
Author Information
1. Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Publication Type:Review
- Keywords:
Low-risk;
Carcinoma, papillary;
Micropapillary;
Active surveillance;
Ethanol injection
- MeSH:
Carcinoma, Papillary;
Incidence;
Incidental Findings;
Mortality;
Prognosis;
Thyroid Gland*;
Thyroid Neoplasms*
- From:Endocrinology and Metabolism
2018;33(2):185-194
- CountryRepublic of Korea
- Language:English
-
Abstract:
The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to cause morbidity and mortality. New understanding about the prognosis of tumor features has led to reclassification of many tumors within the low-risk thyroid category, and to the development of a new one “very low-risk tumors.” Alternative less aggressive approaches to therapy are now available including active surveillance and minimally invasive interventions. In this narrative review, we have summarized the available evidence for the management of low-risk PTC.
